GROα is highly expressed in adenocarcinoma of the colon and down-regulates fibulin-1

Clinical Cancer Research

Volumn 12, Issue 20 PART 1, 2006, Pages 5951-5959

  Wen, Yu ^a   Giardina, Sarah F ^c   Hamming, David ^b   Greenman, Jennifer ^a,b   Zachariah, Emmanuel ^a   Bacolod, Manny D ^c   Liu, Hao ^a   Shia, Jinru ^d   Amenta, Peter S ^a   Barany, Francis ^c   Paty, Phillip ^d   Gerald, William ^d   Notterman, Daniel ^a,b  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b PRINCETON UNIVERSITY   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR2; FIBULIN; G PROTEIN COUPLED RECEPTOR; MATRIX PROTEIN; PROTEIN FIBULIN 1; UNCLASSIFIED DRUG; ALPHA CHEMOKINE; CALCIUM BINDING PROTEIN; CXCL1 PROTEIN, HUMAN; DNA; MESSENGER RNA; RNA; SIGNAL PEPTIDE;

ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; COLON ADENOCARCINOMA; CONTROLLED STUDY; GENE; GROWTH RELATED ONCOGENE ALPHA; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR GROWTH; ADENOCARCINOMA; ANIMAL; CANCER TRANSPLANTATION; CELL SURVIVAL; COLON TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; POLYMERASE CHAIN REACTION; TUMOR CELL LINE; XENOGRAFT;

3T3 CELLS; ADENOCARCINOMA; ANIMALS; CALCIUM-BINDING PROTEINS; CELL LINE, TUMOR; CELL SURVIVAL; CHEMOKINES, CXC; COLONIC NEOPLASMS; DNA, NEOPLASM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; NEOPLASM TRANSPLANTATION; POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TRANSPLANTATION, HETEROLOGOUS;

EID: 33750741945     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-06-0736     Document Type: Article

References (50)

1. Luan J, Shattuck-Brandt R, Haghnegahdar H, et al. Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression. J Leukoc Biol 1997;62:588-97.
2. Haghnegahdar H, Du J, Wang D, et al. The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma. J Leukoc Biol 2000;67:53-62.
3. Notterman DA, Alon U, Sierk AJ, Levine AJ. Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays Cancer Res 2001;61:3124-30.
4. Hogan M, Sherry B, Ritchlin C, et al. Differential expression of the small inducible cytokines GRO α and GRO β by synovial fibroblasts in chronic arthritis: possible role in growth regulation. Cytokine 1994;6:61-9.
5. Rennekampff H, Hansbrough J, Woods V, Dore C, Kiessig V, Schroder J. Role of melanoma growth stimulatory activity (MGSA/gro) on keratinocyte function in wound healing. Arch Dermatol Res 1997;289:204-12.
6. Lane BR, Strieter RM, Coffey MJ, Markovitz DM. Human immunodeficiency virus type 1 (HIV-1)-induced GRO-u production stimulates HIV-1 replication in macrophages and T lymphocytes. J Virol 2001;75:5812-22.
7. Filipovic R, Jakovcevski I, Zecevic N. GRO-α and CXCR2 in the human fetal brain and multiple sclerosis lesions. Dev Neurosci 2003;25:279-90.
8. Tsai H-H, Frost E, To V, et al. The chemokine receptor cxcr2 controls positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration. Cell 2002;110:373-83.
9. Xia M, Hyman B. GROα/KC, a chemokine receptor CXCR2 ligand, can be a potent trigger for neuronal ERK1/2 and PI-3 kinase pathways and for tau hyperphosphorylation-a role in Alzheimer's disease? J Neuroimmunol 2002;122:55-64.
10. Ahuja S, Murphy P. The cxc chemokines growth-regulated oncogene (gro) α, groβ, groγ, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type b, but not the type a, human interleukin-8 receptor. J Biol Chem 1996;271:20545-50.
11. Devalaraja M, Richmond A, Multiple chemotactic factors: fine control or redundancy? TiPS 1999;20:151-6.
12. Owen J, Stricter R, Burdick M, et al. Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine β and γ proteins. Int J Cancer 1997;73:94-103.
13. Rosenkilde M, Schwartz T. Potency of ligands correlates with affinity measured against agonist and inverse agonists but not against neutral ligand in constitutively active chemokine receptor. Mol Pharmacol 2000;57:602-9.
14. Cochran BJ, Reffel AC, Stiles CD. Molecular cloning of gene sequences regulated by platelet-derived growth factor. Cell 1983;33:939-47.
15. Golds E, Mason P, Nyirkos P. Inflammatory cytokines induce synthesis and secretion of gro protein and a neutrophil chemotactic factor but not β 2-microglobulin in human synovial cells and fibroblasts. Biochem J 1989;259:585-8.
16. Anisowicz A, Messineo M, Lee SW, Sager R. An NF-κ B-like transcription factor mediates IL-1/TNF-α induction of gro in human fibroblasts. J Immunol 1991;147:520-7.
17. Fan G-H, Yang W, Sai J, Richmond A. Phosphorylation-independent association of CXCR2 with the protein phosphatase 2A core enzyme. J Biol Chem 2001;276:16960-8.
18. Wang D, Richmond A. Nuclear actor-κ B activation by the CXC chemokine melanoma growth-stimulatory activity/growth-regulated protein involves the MEKK1/p38 mitogen-activated protein kinase pathway. J Biol Chem 2001;276:3650-9.
19. Biswas R DS, Gupta JD, Novotny M, Tebo J, Hamilton TA. Regulation of chemokine mRNA stability by lipopolysaccharide and IL-10. J Immunol 2003;170:6202-8.
20. Wang D, Sai J, Richmond A. Cell surface heparan sulfate participates in CXCL1-induced signaling. Biochemistry 2003;42:1071-7.
21. Thorpe C, Smith W, Hurley B, Acheson D. Shiga toxins induce, superinduce, and stabilize a variety of C-X-C chemokine mRNAs in intestinal epithelial cells, resulting in increased chemokine expression. Infection Immunity 2001;69:6140-7.
22. Wood L, Farmer A, Richmond A. HMGI(Y) and Sp1 in addition to NF-κ B regulate transcription of the MGSA/GRO α gene. Nucleic Acids Res 1995;23:4210-9.
23. Nirodi C, Hart J, Dhawan P, Moon N-S, Nepveu A, Richmond A. The role of CDP in the negative regulation of CXCL1 gene expression. J Biol Chem 2001;276:26122-31.
24. Wang D, Sai J, Carter G, Sachpatzidis A, Lolis E, Richmond A. PAK1 kinase is required for CXCL1-induced chemotaxis. Biochemistry 2002;41:7100-7.
25. Qing J, Maher V, Tran H, Argraves W, Dunstan R, McCormick J. Suppression of anchorage-independent growth and Matrigel invasion and delayed tumor formation by elevated expression of fibulin-1D in human fibroblastoma-derived cell lines. Oncogene 1997;15:2159-68.
26. Du M, Fan X, Hong E, Chen JJ. Interaction of oncogenic papillomavirus E6 proteins with fibulin-1. Biochem Biophys Res Commun 2002;296:962-9.
27. Grutkoski P, Graeber C, Ayala A, Simms H. Paracrine suppression of apoptosis by cytokine-stimulated neutrophils involves divergent regulation of NF-κB, Bcl-X(L), and Bak. Shock 2002;17:47-54.
28. Leuenroth S, Lee C, Grutkoski P, Keeping H, Simms H. Interleukin-8- induced suppression of polymorphonuclear leukocyte apoptosis is mediated by suppressing CD95 (Fas/Apo-1) Fas-1 interactions. Surgery 1998;124:409-17.
29. Baggiolini M. Chemokines and leukocyte traffic. Nature 1998;392:565-8.
30. Wang D, Yang W, DuJ, et al. MGSA/GRO-mediated melanocyte transformation involves induction of Ras expression. Oncogene 2000;19:4647-59.
31. Dhawan P, Richmond A. Role of CXCL1 in tumorigenesis of melanoma. J Leukoc Biol 2002;72:9-18.
32. Schteingart DE, Giordano TJ, Benitez RS, et al. Overexpression of CXC chemokines by an adrenocortical carcinoma: a novel clinical syndrome. J Clin Endocrinol Metab 2001;86:3968-74.
33. Loukinova E, Dong G, Enamorado-Ayalya I, et al. Growth regulated oncogene-a expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC Receptor-2 dependent mechanism. Oncogene 2000;19:3477-86.
34. Moore BB, Arenberg OA, Stoy K, et al. Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells. Am J Pathol 1999;154:1503-12.
35. Jacoby R, Alexander R, Raicht R, Brasitus T. K-ras oncogene mutations in rat colon tumors induced by N-methyl-N-nitrosourea. Carcinogenesis 1992;13:45-9.
36. de Jong TA, Skinner SA, Malcontenti-Wilson C, et al. Inhibition of rat colon tumors by sulindac and sulindac sulfone is independent of K-ras (codon 12) mutation. Am J Physiol Gastrointest Liver Physiol 2000;278:G266-72.
37. Imada A, Ina K, Shimada M, et al. Coordinate upregulation of interleukin-8 and growth-related gene product-a is present in the colonic mucosa of inflammatory bowel disease. Scand J Gastroenterol 2001;36:854-64.
38. Munkholm P. The incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther 2003;18:1-5.
39. Argraves W, Tran H, Burgess W, Dickerson K. Fibulin is an extracellular matrix and plasma glycoprotein with repeated domain structure. J Cell Biol 1990;111:3155-64.
40. Hayashido Y, Lucas A, Rougeot C, Godyna S, Argraves W, Rochefort H. Estradiol and fibulin-1 inhibit motility of human ovarian- and breast-cancer cells induced by fibronectin. Int J Cancer 1998;75:654-8.
41. Roark E, Keene D, Haudenschild C, Godyna S, Little C, Argraves W. The association of human fibulin-1 with elastic fibers: an immunohistological, ultrastructural, and RNA study. J Histochem Cytochem 1995;43:401-11.
42. Pupa S, Argraves W, Forti S, et al. Immunological and pathobiological roles of fibulin-1 in breast cancer. Oncogene 2004;23:2153-60.
43. Kubota Y, Kuroki R, Nishiwaki K. A fibulin-1 homolog interacts with an ADAM protease that controls cell migration in C. elegans. Curr Biol 2004;14:2011-8.
44. Qing J, Wei D, Maher VM, McCormick JJ. Cloning and characterization of a novel gene encoding a putative transmembrane protein with altered expression in some human transformed and tumor-derived cell lines. Oncogene 1999;18:335-42.
45. Greene L, Twal W, Duffy M, et al. Elevated expression and altered processing of fibulin-1 protein in human breast cancer. Br J Cancer 2003;88:871-8.
46. Moll F, Katsaros D, Lazennec G, et al. Estrogen induction and overexpression of fibulin-1C mRNA in ovarian cancer cells. Oncogene 2002;21:1097-107.
47. Twal WO, Czirok A, Hegedus B, et al. Fibulin-1 suppression of fibronectin-regulated cell adhesion and motility. J Cell Sci 2001;114:4587-98.
48. Gallagher WM, Currid CA, Whelan LC. Fibulins and cancer: friend or foe? Trends Mol Med 2005;11:336-40.
49. Panja A, Goldberg S, Eckmann L, Krishen P, Mayer L. The regulation and functional consequence of proinflammatory cytokine binding on human intestinal epithelial cells. J Immunol 1998;161:3675-84.
50. Shattuck R, Wood L, Jaffe G, Richmond A. MGSA/GRO transcription is differentially regulated in normal retinal pigment epithelial and melanoma cells. Mol Cell Biol 1994;14:791-802.